US Patent Issued to Mayo Foundation for Medical Education and Research on July 15 for "Method of using NAP-2 and TGF-Alpha to improve cardiac function" (Minnesota Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,676, issued on July 15, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).

"Method of using NAP-2 and TGF-Alpha to improve cardiac function" was invented by Atta Behfar (Rochester, Minn.), Andre Terzic (Rochester, Minn.) and Ruben Jose Crespo-Diaz (Rochester, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse ...